Shares of India's Ranbaxy slide 19% on new US FDA ban
Shares in one of India's biggest drugmakers, Ranbaxy Laboratories, slid 19 percent Friday after the US Food and Drug Administration suspended imports from a fourth manufacturing plant of the firm.
Jan 24, 2014
0
0